X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (108) 108
index medicus (106) 106
male (74) 74
female (70) 70
dermatology (65) 65
middle aged (62) 62
aged (61) 61
melanoma (57) 57
adult (51) 51
oncology (49) 49
skin neoplasms - pathology (48) 48
prognosis (40) 40
aged, 80 and over (38) 38
survival (28) 28
melanoma - pathology (27) 27
retrospective studies (24) 24
cancer (23) 23
treatment outcome (21) 21
metastasis (20) 20
surgery (20) 20
young adult (19) 19
biopsy (18) 18
malignant-melanoma (18) 18
neoplasm staging (18) 18
risk factors (18) 18
skin (18) 18
t-cell lymphoma (17) 17
analysis (16) 16
cutaneous melanoma (16) 16
mycosis fungoides (16) 16
skin neoplasms - drug therapy (16) 16
follow-up studies (14) 14
skin neoplasms - diagnosis (14) 14
disease-free survival (13) 13
medicine, research & experimental (13) 13
sentinel lymph node biopsy (13) 13
adolescent (12) 12
flow cytometry (12) 12
prospective studies (12) 12
tumors (12) 12
classification (11) 11
diagnosis (11) 11
disease progression (11) 11
european-organization (11) 11
ipilimumab (11) 11
sezary-syndrome (11) 11
skin neoplasms - mortality (11) 11
care and treatment (10) 10
epidemiology (10) 10
further section (10) 10
immunotherapy (10) 10
lymphomas (10) 10
management (10) 10
melanoma - secondary (10) 10
therapy (10) 10
diagnosis, differential (9) 9
disease (9) 9
electrochemotherapy (9) 9
italy (9) 9
melanoma - drug therapy (9) 9
melanoma - epidemiology (9) 9
metastatic melanoma (9) 9
multivariate analysis (9) 9
mycosis-fungoides (9) 9
patients (9) 9
sezary syndrome (9) 9
skin neoplasms - surgery (9) 9
survival rate (9) 9
time factors (9) 9
chemotherapy (8) 8
expression (8) 8
lymph nodes - pathology (8) 8
medical research (8) 8
melanoma - diagnosis (8) 8
melanoma - mortality (8) 8
metastases (8) 8
mycosis (8) 8
mycosis fungoides - pathology (8) 8
phase-ii (8) 8
prognostic-factors (8) 8
risk (8) 8
sentinel lymph node (8) 8
skin - pathology (8) 8
skin neoplasms - epidemiology (8) 8
abridged index medicus (7) 7
antineoplastic agents - therapeutic use (7) 7
breast-cancer (7) 7
clinical trials (7) 7
eortc classification (7) 7
health aspects (7) 7
immunology (7) 7
kaplan-meier estimate (7) 7
lymphoma (7) 7
medical prognosis (7) 7
medicine & public health (7) 7
melanoma - surgery (7) 7
primary cutaneous melanoma (7) 7
recurrence (7) 7
regression (7) 7
sezary syndrome - pathology (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2019, Volume 20, Issue 8, pp. 1048 - 1049
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10094, pp. 555 - 566
Journal Article
Journal Article
Journal of translational medicine, ISSN 1479-5876, 02/2018, Volume 16, Issue 1, pp. 33 - 1
In the original version of this article [1], published on 7 November 2017, affiliation 18 has been incorrectly assigned to the authors Serena Magi and Laura... 
Journal Article
Journal Article
Seminars in cancer biology, ISSN 1044-579X, 08/2019, Volume 59, pp. 290 - 297
Melanoma has always been described as an immunogenic tumor. Despite that, until 2011 the standard of care in metastatic melanoma was chemotherapy, with low... 
Journal Article
Case Reports in Dermatology, ISSN 1662-6567, 09/2019, Volume 11, Issue 1, pp. 23 - 28
Upon the association of biologic treatments with reactivation of latent tuberculosis infection (LTBI), screening for Mycobacterium tuberculosisinfection and... 
Psoriasis | Latent tuberculosis infection | Secukinumab
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 7/2018, Volume 67, Issue 7, pp. 1175 - 1176
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00262-018-2153-9 
Oncology | Cancer Research | Immunology | Medicine & Public Health | ONCOLOGY | CANCER-IMMUNOTHERAPY | IMMUNOLOGY | Mycoses | Mycosis | Mycosis fungoides | Suppressor cells
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 71, Issue 6, pp. 1102 - 1109.e1
Background BRAF inhibitor (BRAFi) and MEK inhibitor (MEKi) frequently cause cutaneous adverse events. Objective We sought to investigate the cutaneous safety... 
Dermatology | cutaneous adverse event | rash | histology | inflammation | therapy | squamous cell carcinoma | squamous cell carcinoma therapy | ACTIVATION | IMPROVED SURVIVAL | OPEN-LABEL | DERMATOLOGY | METASTATIC MELANOMA | MEK INHIBITION | PATHWAY | RESISTANCE | RAF INHIBITORS | MUTATIONS | VEMURAFENIB | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Skin Neoplasms - drug therapy | Follow-Up Studies | Oximes - adverse effects | Humans | Middle Aged | Oximes - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Imidazoles - administration & dosage | Male | Protein Kinase Inhibitors - adverse effects | Indoles - administration & dosage | Young Adult | Pyridones - administration & dosage | Carcinoma, Squamous Cell - mortality | Skin Neoplasms - mortality | Aged, 80 and over | Adult | Female | Retrospective Studies | Piperidines - administration & dosage | Imidazoles - adverse effects | Pyrimidinones - adverse effects | Azetidines - adverse effects | Kaplan-Meier Estimate | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Protein Kinase Inhibitors - administration & dosage | Azetidines - administration & dosage | Carcinoma, Squamous Cell - drug therapy | Indoles - adverse effects | Melanoma - drug therapy | Piperidines - adverse effects | Adolescent | Sulfonamides - adverse effects | Aged | Pyrimidinones - administration & dosage | Pyridones - adverse effects | Sulfonamides - administration & dosage | Melanoma - mortality | Complications and side effects | Medical colleges | Melanoma
Journal Article
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3592 - 3592
Abstract OBJECTIVES: To determine whether individual items on patient-reported outcome measures show significant differences over the course of treatment for... 
Journal Article
Annals of Surgical Oncology, ISSN 1068-9265, 1/2018, Volume 25, Issue 1, pp. 271 - 279
Journal Article